Parallel Advisors’s Immunovant IMVT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $20.9K | Buy |
1,306
+1,299
| +18,557% | +$20.8K | ﹤0.01% | 2155 |
|
2025
Q1 | $120 | Sell |
7
-31
| -82% | -$531 | ﹤0.01% | 3415 |
|
2024
Q4 | $941 | Buy |
+38
| New | +$941 | ﹤0.01% | 3098 |
|
2024
Q3 | – | Hold |
0
| – | – | – | 3425 |
|
2023
Q2 | – | Sell |
-24
| Closed | -$372 | – | 3440 |
|
2023
Q1 | $372 | Hold |
24
| – | – | ﹤0.01% | 3193 |
|
2022
Q4 | $426 | Hold |
24
| – | – | ﹤0.01% | 3062 |
|
2022
Q3 | $0 | Buy |
+24
| New | – | ﹤0.01% | 3300 |
|
2022
Q1 | – | Sell |
-382
| Closed | -$3K | – | 3103 |
|
2021
Q4 | $3K | Buy |
+382
| New | +$3K | ﹤0.01% | 2570 |
|
2021
Q3 | – | Sell |
-14,262
| Closed | -$151K | – | 3129 |
|
2021
Q2 | $151K | Hold |
14,262
| – | – | 0.01% | 791 |
|
2021
Q1 | $229K | Buy |
+14,262
| New | +$229K | 0.01% | 590 |
|